Role of inflammasomes in multiple sclerosis and their potential as therapeutic targets
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-2094
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Role of inflammasomes in multiple sclerosis and their potential as therapeutic targets ; volume:17 ; number:1 ; day:2 ; month:9 ; year:2020 ; pages:1-15 ; date:12.2020
Journal of neuroinflammation ; 17, Heft 1 (2.9.2020), 1-15, 12.2020
- Urheber
-
Govindarajan, Vaidya
de Rivero Vaccari, Juan Pablo
Keane, Robert W.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12974-020-01944-9
- URN
-
urn:nbn:de:101:1-2020102322144319312360
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:26 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Govindarajan, Vaidya
- de Rivero Vaccari, Juan Pablo
- Keane, Robert W.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Granulocyte-Macrophage Colony-Stimulating Factor as a Therapeutic Target in Multiple Sclerosis
Autotaxin in encephalitogenic CD4 T cells as a therapeutic target for multiple sclerosis
Astroglial connexin 43 is a novel therapeutic target for chronic multiple sclerosis model
CD146: a potential therapeutic target for systemic sclerosis
Central nervous system intrinsic inflammation as driver and therapeutic target of progression in multiple sclerosis
Luteolin as a therapeutic option for multiple sclerosis
erratum “Current Evidence and Therapeutic Strategies for Multiple Sclerosis”
CNS glucose metabolism in Amyotrophic Lateral Sclerosis: a therapeutic target?
Brain atrophy in multiple sclerosis: therapeutic, cognitive and clinical impact
Multiple sclerosis
Multiple sclerosis
Time to target brain atrophy and neurodegeneration in multiple sclerosis
Granulocyte-Macrophage Colony-Stimulating Factor as a Therapeutic Target in Multiple Sclerosis
Autotaxin in encephalitogenic CD4 T cells as a therapeutic target for multiple sclerosis
Astroglial connexin 43 is a novel therapeutic target for chronic multiple sclerosis model
CD146: a potential therapeutic target for systemic sclerosis
Central nervous system intrinsic inflammation as driver and therapeutic target of progression in multiple sclerosis
Luteolin as a therapeutic option for multiple sclerosis
erratum “Current Evidence and Therapeutic Strategies for Multiple Sclerosis”
CNS glucose metabolism in Amyotrophic Lateral Sclerosis: a therapeutic target?
Brain atrophy in multiple sclerosis: therapeutic, cognitive and clinical impact
Multiple sclerosis
Multiple sclerosis
Time to target brain atrophy and neurodegeneration in multiple sclerosis
Granulocyte-Macrophage Colony-Stimulating Factor as a Therapeutic Target in Multiple Sclerosis
Autotaxin in encephalitogenic CD4 T cells as a therapeutic target for multiple sclerosis
Astroglial connexin 43 is a novel therapeutic target for chronic multiple sclerosis model
CD146: a potential therapeutic target for systemic sclerosis
Central nervous system intrinsic inflammation as driver and therapeutic target of progression in multiple sclerosis
Luteolin as a therapeutic option for multiple sclerosis
erratum “Current Evidence and Therapeutic Strategies for Multiple Sclerosis”
CNS glucose metabolism in Amyotrophic Lateral Sclerosis: a therapeutic target?
Brain atrophy in multiple sclerosis: therapeutic, cognitive and clinical impact
Multiple sclerosis
Multiple sclerosis